We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$99.9M
2
UBER icon
Uber
UBER
+$71M
3
AVGO icon
Broadcom
AVGO
+$36.2M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$32.6M
5
LULU icon
lululemon athletica
LULU
+$32.3M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$139M
2
AAPL icon
Apple
AAPL
+$72.7M
3
VMW
VMware, Inc
VMW
+$47.1M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$42.3M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$35.5M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFX
3751
DELISTED
BowFlex Inc.
BFX
$750 ﹤0.01%
+975
New +$664
AMTD
3752
AMTD IDEA Group
AMTD
$71.5M
$716 ﹤0.01%
398
– –
BFRA
3753
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$714 ﹤0.01%
288
– –
QTTB icon
3754
Q32 Bio
QTTB
$482M
$713 ﹤0.01%
65
– –
CTRN icon
3755
Citi Trends
CTRN
$600M
$707 ﹤0.01%
25
– –
LITS
3756
Lite Strategy Inc
LITS
$31.6M
$707 ﹤0.01%
122
– –
TFII icon
3757
TFI International
TFII
$11.3B
$679 ﹤0.01%
5
– –
ASLN
3758
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$674 ﹤0.01%
162
– –
SPRO icon
3759
Spero Therapeutics
SPRO
$73.5M
$673 ﹤0.01%
458
– –
HLTH
3760
DELISTED
Cue Health Inc. Common Stock
HLTH
$651 ﹤0.01%
4,022
– –
AXDX
3761
DELISTED
Accelerate Diagnostics
AXDX
$642 ﹤0.01%
164
– –
RJET
3762
Republic Airways Holdings
RJET
$996M
$634 ﹤0.01%
42
– –
MMAT
3763
DELISTED
Meta Materials Inc. Common Stock
MMAT
$623 ﹤0.01%
94
– –
SAND
3764
DELISTED
Sandstorm Gold
SAND
$618 ﹤0.01%
+123
New +$586
WGS icon
3765
GeneDx Holdings
WGS
$2.08B
$616 ﹤0.01%
224
– –
VET icon
3766
Vermilion Energy
VET
$1.68B
$603 ﹤0.01%
50
– –
BNTC icon
3767
Benitec Biopharma
BNTC
$451M
$602 ﹤0.01%
186
– –
WKEY
3768
WISeKey
WKEY
$75.6M
$601 ﹤0.01%
338
– –
IPHA
3769
Innate Pharma
IPHA
$168M
$574 ﹤0.01%
205
– –
IMO icon
3770
Imperial Oil
IMO
$61.1B
$571 ﹤0.01%
10
– –
EBIX
3771
DELISTED
Ebix Inc
EBIX
$557 ﹤0.01%
536
-81,113
-99% -$408K
EIGR
3772
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$522 ﹤0.01%
77
– –
MTA
3773
Metalla Royalty & Streaming
MTA
$785M
$492 ﹤0.01%
160
– –
UEIC icon
3774
Universal Electronics
UEIC
$60.6M
$469 ﹤0.01%
50
– –
CELU icon
3775
Celularity
CELU
$19.8M
$467 ﹤0.01%
189
– –
149 150
151
152 153

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.